Skalafouris, Christian
Reny, Jean-Luc
Stirnemann, Jérôme
Grosgurin, Olivier
Eggimann, François
Grauser, Damien
Teixeira, Daniel
Jermini, Megane
Bruggmann, Christel
Bonnabry, Pascal
Guignard, Bertrand
Article History
Received: 15 August 2021
Accepted: 19 May 2022
First Online: 31 May 2022
Declarations
:
: The project was submitted to the Ethics Committee of the Canton of Geneva, Switzerland (Req-2019-01266) that approved experimental protocol, and the need for informed consent was waived as this quality-improvement study was set up as standard practice not falling within the scope of the Swiss law on research on human beings: the project was part quality improvement of care process without the objective of being a scientific research on human diseases or on the structure and functioning of the human body. All methods were performed in accordance with the relevant guidelines and regulations. Clinical pharmacist’s interventions were exclusively dedicated to physicians who finally decided on a prescription change. All patients admitted to the internal medicine department under cover of clinical pharmacy services were eligible as no exclusion criteria was defined. Patients did not provide informed consent as this service was implemented as standard of care.
: Not applicable.
: All authors declare that they have no competing interests.